GETWAB

02 / Federal Business Size

Federal contract market at a glance

Measured consistently across FY 2020–FY 2026.

Net obligations$1.10M
Contract actions71
Awards / PIIDs44
Federal customers1
Contracting offices4
Average action$15.5K
Active fiscal years7
Data coverageFY 2020–FY 2026

Across FY 2020–FY 2026, FPDS records attribute $1.10M in net contract obligations to PHARMARON, INC. across 71 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.

03 / Spending Trend

PHARMARON, INC. contract spending by year

Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.

Total obligations$35.3K
FY 2026
ObligationsHistorical spending range
Fiscal yearObligationsActionsFederal customersChange
FY 2020$93.7K81—
FY 2021$327.4K131+249.6%
FY 2022$174.5K131−46.7%
FY 2023$231.6K231+32.7%
FY 2024$235.5K51+1.7%
FY 2025$4.9K21−97.9%
FY 2026$35.3K71+621.8%

04 / Federal Customers

Which federal agencies buy from PHARMARON, INC.?

Ranked by net obligations during FY 2020–FY 2026.

AgencyCodeObligationsActionsVendor share
7529$1.10M71100.0%

05 / Contracting Offices

Which contracting offices buy from PHARMARON, INC.?

Ranked by net obligations during FY 2020–FY 2026.

06 / Top NAICS Industries

Which industries define this vendor’s federal work?

NAICSDescriptionObligationsActionsCustomersShare
541380TESTING LABORATORIES AND SERVICES$1.21M571110.0%
541715RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$50.3K114.6%
541990ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES$28.6K612.6%
325412PHARMACEUTICAL PREPARATION MANUFACTURING$24.6K112.2%
325413IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING$11.9K211.1%
325414BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$10.0K210.9%
325998ALL OTHER MISCELLANEOUS CHEMICAL PRODUCT AND PREPARATION MANUFACTURING-$93.2K11-8.5%
621511MEDICAL LABORATORIES-$142.3K11-12.9%

07 / Top Product and Service Codes

What products and services does the government buy from this vendor?

PSCDescriptionObligationsActionsCustomersShare
Q301MEDICAL- LABORATORY TESTING$1.01M59191.7%
B504SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL$44.5K614.0%
R499SUPPORT- PROFESSIONAL: OTHER$36.6K413.3%
6505DRUGS AND BIOLOGICALS$10.0K210.9%

08 / Competition Pattern

How was PHARMARON, INC.’s federal work competed?

Competition categories describe the procurement path recorded on the underlying contract actions.

Competition categoryObligationsActions
Other / unknown$1.01M31
Competed under SAP$268.8K27
Competed-$84.0K12
Not competed-$93.2K1

09 / Recent Contract Awards

What contract actions were recorded most recently for PHARMARON, INC.?

The latest recorded PIIDs connect this profile to the underlying federal award search.

Award / PIIDSignedObligationAgency / officeNAICSPSC
75N95021P00401Sep 16, 2026-$6.5KNATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH NIDA541380Q301

10 / Interpreting the Profile

How should you evaluate PHARMARON, INC. as a federal contractor?

Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.

01

Separate obligations from revenue

FPDS obligations are government accounting actions and may include later deobligations.

02

Follow customer concentration

Agency and office concentration reveals where the vendor’s federal relationships are strongest.

03

Test market overlap

NAICS and PSC shares show whether the vendor competes in the same markets as your company.

04

Inspect the awards

Open the PIIDs to verify dates, offices, classifications, and transaction history.